2023-07-05 06:32:10 ET
- FSD Pharma ( NASDAQ: HUGE ) Co-Founder and President Zeeshan Saeed to succeed Anthony Durkacz, who has been serving as the Interim CEO since July 2021.
- Mr. Durkacz and Mr. Saeed will continue to hold their positions as Executive Co-Chairman of the Board of Directors.
- The company will streamline operations to focus on the development of UNBUZZD for consumer and hospital markets and Lucid-MS for neurodegenerative disorders under the leadership of Mr. Saeed
- Source: Press Release
For further details see:
FSD Pharma appoints Zeeshan Saeed as CEO